Tilray Brands, Inc. (2HQ.DE)
EUR 1.16
(0.43%)
EUR 1.16
(0.43%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 348.35 Million USD | -4.79% |
| 2022 | 365.86 Million USD | -31.12% |
| 2021 | 531.15 Million USD | -40.26% |
| 2020 | 889.05 Million USD | 203.55% |
| 2019 | 292.88 Million CAD | -17.83% |
| 2018 | 356.43 Million CAD | 1521.97% |
| 2017 | 21.97 Million CAD | -6.86% |
| 2016 | 23.59 Million CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 287.91 Million USD | -23.66% |
| 2023 Q3 | 365.46 Million USD | 0.74% |
| 2023 Q4 | 348.35 Million USD | -4.68% |
| 2023 FY | 348.35 Million USD | -4.79% |
| 2023 Q1 | 280.71 Million USD | -23.27% |
| 2023 Q2 | 362.76 Million USD | 29.23% |
| 2022 Q3 | 321.1 Million USD | -16.48% |
| 2022 Q1 | 568.14 Million USD | 6.96% |
| 2022 FY | 365.86 Million USD | -31.12% |
| 2022 Q4 | 365.86 Million USD | 13.94% |
| 2022 Q2 | 384.44 Million USD | -32.33% |
| 2021 Q3 | 638.49 Million USD | -15.54% |
| 2021 Q1 | 829.88 Million USD | -6.66% |
| 2021 FY | 531.15 Million USD | -40.26% |
| 2021 Q4 | 531.15 Million USD | -16.81% |
| 2021 Q2 | 755.93 Million USD | -8.91% |
| 2020 FY | 889.05 Million USD | 203.55% |
| 2020 Q2 | 404.67 Million USD | 30.83% |
| 2020 Q3 | 707.21 Million CAD | 74.76% |
| 2020 Q4 | 889.05 Million USD | 25.71% |
| 2020 Q1 | 309.32 Million USD | 5.61% |
| 2019 FY | 292.88 Million CAD | -17.83% |
| 2019 Q3 | 351.33 Million USD | -5.89% |
| 2019 Q2 | 373.33 Million USD | 6.93% |
| 2019 Q4 | 292.88 Million USD | -16.64% |
| 2019 Q1 | 349.15 Million USD | -2.04% |
| 2018 Q1 | 40.05 Million USD | 82.25% |
| 2018 Q2 | 38.53 Million USD | -3.78% |
| 2018 Q4 | 356.43 Million USD | 652.42% |
| 2018 Q3 | 47.37 Million USD | 22.93% |
| 2018 FY | 356.43 Million CAD | 1521.97% |
| 2017 Q3 | 23.55 Million USD | -2.27% |
| 2017 Q2 | 24.1 Million USD | -2.97% |
| 2017 Q1 | 24.84 Million CAD | 5.29% |
| 2017 FY | 21.97 Million CAD | -6.86% |
| 2017 Q4 | 21.97 Million USD | -6.72% |
| 2016 Q4 | 23.59 Million CAD | 333.25% |
| 2016 Q2 | 5.06 Million CAD | -5.19% |
| 2016 Q1 | 5.34 Million CAD | 0.0% |
| 2016 FY | 23.59 Million CAD | 0.0% |
| 2016 Q3 | 5.44 Million CAD | 7.5% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| MPH Health Care AG | 8.33 Million EUR | -4080.284% |
| Apontis Pharma AG | 6 Million EUR | -5705.95% |
| Dermapharm Holding SE | 950.7 Million EUR | 63.358% |
| Evotec SE | 477.11 Million EUR | 26.986% |
| MERCK Kommanditgesellschaft auf Aktien | 8.84 Billion EUR | 96.062% |
| PharmaSGP Holding SE | 65.37 Million EUR | -432.9% |
| SynBiotic SE | 2.89 Million EUR | -11939.524% |